Trial Details
Not AvailableBasic Information
| Clinical ID | c5091 |
|---|---|
| Identifier | EUCTR2016-000522-18-FR |
| Trial Title | Risk stratified randomized controlled trial in paediatric Crohn Disease: Methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or at high risk for aggressive disease course, respectively a treatment strategy - REDUCE- |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: humiraPharmaceutical Form: Solution for infusionINN or Proposed INN: ADALIMUMABCAS Number: 331731-18-1Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 160-Product Name: Imu |
Participant Information
| Sponsor | PIBDNet |
|---|---|
| City | NULL |
| Country/Region | France;Hungary;Czech Republic;Canada;Poland;Belgium;Israel;Netherlands;Germany;Italy;United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |